As we hunker down for months of culture wars over abortion, here's a question worth pondering: Wouldn't it be nice if the governing party in Washington cared as much about the well-being of children and their mothers during and after birth as they do about fetuses?
The high prices for specialty drugs are forcing physicians, patients and their families to factor in financial toxicity when choosing an appropriate therapy.
President Donald Trump can change his policy of separating children from their undocumented migrant families, but he can never undo the damage already inflicted on thousands of innocent children.
Despite numerous promises to protect such patients, the president now proposes returning to the not-too-distant past when people with cancer, diabetes and chronic heart conditions could only buy healthcare coverage at exorbitant rates—if they could find it at all.
As more rural hospitals close their doors, patients are left with fear and apprehension about the future of their healthcare and the local economy. As in any relationship, trust and communication are key.
In the news about Roseanne Barr losing her show, a California Chick-fil-A raising its minimum wage and budget cuts forcing the closure of Agency for Healthcare Research and Quality's Guideline Clearinghouse, there are lessons to learn about U.S. healthcare.
Unless Congress changes the law or the FDA changes guidance on biosimilar development, patients and payers can expect to pay exorbitant prices for biologics long after the drugs' patents have expired.
Social scientists know a lot about the root causes of so much of the ill-health in our society, yet healthcare systems have rarely acted on that knowledge. That's finally starting to change.
The next Veterans Affairs secretary faces a tough job. The agency's ability to meet the special healthcare needs of a rapidly changing veteran population hangs in the balance.
How can the federal government meet its Medicare obligations to retirees—half of whom have no personal savings or pensions—when it continually reduces taxes?
The nation needs a far more robust federal nutrition program, just as it needs more robust housing, job training, early childhood development and other social programs that tackle the so-called social determinants of health.
Everyone in Washington agrees bold action to combat the opioid epidemic is long overdue. Yet the legislation advancing in Congress barely qualifies as a start.